Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE(R)-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in ...

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...

MPESB ITI Training Officer Recruitment 2026: Notification For 1120 Positions Out; Registration Process Starts Tomorrow

MPESB ITI Training Officer Recruitment 2026: The Madhya Pradesh Employees Selection Board (MPESB) has issued an official ...

MPESB ITI training officer recruitment 2026: Registration for 1,120 posts begins tomorrow, check details here

Madhya Pradesh Employees Selection Board announced recruitment for 1120 ITI Training Officer positions. Applications open ...

Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in ...

Immunomic Therapeutics, Inc. ("ITI"), a privately held clinical-stage biotechnology company pioneering nucleic acid-based immunotherapy, today announced that the U.S. Food and Drug Administration (FDA ...